We expect revenue/EBITDA/PAT CAGR of 60%/59%/55% over FY26–28 from 42%/26%/24% over FY21–26, driven by...
Prashant Jain’s 3P Investment Managers has acquired a 2.5% stake in Entero Healthcare Solutions...
We see inorganic potential to tap into the 4W E&E space which can open...
We expect AIL to deliver a stellar revenue/EBITDA/PAT growth of 44%/58%/64% over FY26-FY28, owing...
We model 12/15/20% revenue/EBITDA/APAT CAGRs over FY26–29E, underpinned by improving profitability and consistent growth...
At the current market price of Rs 312, the stock trades at FY27E/FY28E P/E...
MCX premium today is narrowly concentrated: crude oil and natural gas account for ~75%...
Core pipe business sustains growth momentum, contribution from NPC acquisition to be fully reflected...
The company operates in the corporate spend-management ecosystem, combining SaaS, fintech, prepaid cards, employee...
EEI - led growth provides strong earnings visibility